Developing regions vs Iceland: Proportion of the target population who received the final dose of
Developing regions
26.0%
in 2024
Iceland
89.0%
in 2024
Developing regions rank
24th
Iceland rank
11th
Proportion of the target population who received the final dose of over time
- Developing regions
- Iceland
How they compare
Iceland currently reports 89.0% against 26.0% in Developing regions, a difference of 63.0%.
That makes Iceland's figure about 3.4 times Developing regions's.
Across all 13 years both countries report, Iceland has been ahead every year.
Developing regions ranks 24th and Iceland ranks 11th of 35 groups.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Developing regions | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6.6% | 89.0% | 82.4% | Iceland |
| 2020s | 14.0% | 87.6% | 73.6% | Iceland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Developing regions or Iceland?
- Iceland, at 89.0% against 26.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Developing regions and Iceland?
- 63.0%, with Iceland ahead.
- How many years of comparable data are there for Developing regions and Iceland?
- 13 years are reported by both, from 2012 to 2024.
- How do Developing regions and Iceland rank globally for proportion of the target population who received the final dose of?
- Developing regions ranks 24th and Iceland ranks 11th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.